Moncef Slaoui Biography and Wiki
Moncef Slaoui (born as Moncef Mohamed Slaoui) is an American researcher and former head of GlaxoSmithKline’s vaccines department. He is best known for being responsible for the global vaccine business at GSK through its integration of the Novartis vaccine acquisition in 2015. Moncef is also a Partner at Medicxi and has been with the firm since September 2017. He currently serves on the board of Divide & Conquer, Monopteros, and has an active role in several other Medicxi portfolio companies to support their development.
Amidst the Corona Virus pandemic, on 13th May 2020, President Trump named Moncef together with United States Army four-star general who serves as the commanding general of United States Army Materiel Command, Gustave F. Perna to lead Operation Warp Speed, the government’s effort to speed up the development of a vaccine for the coronavirus.
The two men will lead a crash development program ordered by Mr. Trump that is meant to ensure that a vaccine will be ready for wide distribution in the United States by as early as next year. In late April, officials at the Department of Health and Human Services confirmed the effort but provided few details.
10 Quick Facts About Moncef Slaoui
- Name: Moncef Slaoui
- Age: 61
- Birthday: 27 July
- Zodiac Sign: Leo
- Height: Around 5 feet 6 inches (1.67 m)
- Nationality: American
- Occupation: Researcher
- Marital Status: Married
- Salary: Under review
- Net worth: Between $1 million and $5 million
Moncef Slaoui Age
Moncef is 60 years as of 2019, he was born on 27 July 1959 in Agadir, Morocco. Moncef celebrates his birthday on 27th July every year. He will be turning 61 years old on 27 July 2020.
Moncef Slaoui Height and Weight
Moncef stands at an average height and moderate weight. He appears to be quite tall in stature if his photos, relative to his surroundings, are anything to go by. However, details regarding his actual height and other body measurements are currently not publicly available. We are keeping tabs and will update this information once it is out.
Moncef Slaoui Family
After doing our research, details about his parents are not known to the public. He has four siblings, his younger sister who died at a young age from pertussis. One of his two young brothers and pediatrician died from pancreatic cancer. His brother, Mohamed, is a specialist in gastroenterology, and his older sister, Hadia, is a university professor of French literature in Morocco.
Moncef Slaoui Wife
Moncef is married to Kristen Belmonte. Kristen B. Slaoui, Ph.D. is Vice President and Head of Business Development for GlaxoSmithKline’s (GSK) Pharmaceuticals Commercial Portfolio. She has spent nearly 20 years with GSK, first in the research labs, where her work in pulmonary disease resulted in the discovery of the long-acting muscarinic receptor antagonist in the approved medicines.
She holds multiple patents, has authored more than 40 original peer-reviewed publications, and she has had ongoing roles as a peer reviewer for a dozen established medical journals. Since joining GSK’s Business Development teams in 2006, she has held various roles of increasing seniority and has executed more than $30 billion worth of deals and acquisitions
Moncef Slaoui Net Worth
Moncef has enjoyed a long career in the health industry Through proceeds from his work as a doctor, he has been able to accumulate a modest fortune. Moncef is estimated to have a net worth of about $1 million-$5 million.
Moncef Slaoui Measurements and Facts
Here are some interesting facts and body measurements you should know about Moncef Slaoui.
Moncef Slaoui Bio and Wiki
- Full Names: Moncef Mohammed Slaoui
- Popular As: Moncef Slaoui
- Gender: Male
- Occupation / Profession: Doctor
- Nationality: Moroccan
- Race / Ethnicity: Not Available
- Religion: Muslim
- Sexual Orientation: Straight
Moncef Slaoui Birthday
- Age / How Old?: 60yrs(2019)
- Zodiac Sign: Not Available
- Date of Birth: 27 July 1959
- Place of Birth: Agadir, Morocco
- Birthday: 27 July
Moncef Slaoui Body Measurements
- Body Measurements: Not Available
- Height / How Tall?: Not Known
- Weight: Not Known
- Eye Color: Not Available
- Hair Color: Not Available
- Shoe Size: Not Available
Moncef Slaoui Family and Relationship
- Father (Dad): Not Known
- Mother: Not Known
- Siblings (Brothers and Sisters): 4
- Marital Status: Married
- Wife/Spouse: Married to Kristen Belmonte
- Children: 3 sons
Moncef Slaoui Networth and Salary
- Net Worth: $1 million-$5 million
- Salary: Under Review
- Source of Income: Doctor
Moncef Slaoui House and Cars
- Place of living: To be Updated
- Cars: Car Brand to be Updated
Moncef Slaoui and Trump
The Trump administration has chosen their drug (Moncef Slaoui) and vaccine development czar to head up the R&D side of the Covid-19 attack plan, but it’s not Elias Zerhouni.
At a Rose Garden event, Trump named former GlaxoSmithKline vaccine head Moncef Slaoui and four-star general Gustave Perna to lead the charge, which aims to deliver a COVID-19 vaccine by the end of the year.
Already, based on early data for one undisclosed program, Slaoui said he’s confident the group can deliver. The GSK vet now serves on the board of Moderna, whose mRNA vaccine candidate is in human testing against COVID-19.
The U.S. government’s “Operation Warp Speed” aims to deliver a coronavirus vaccine to Americans by the end of the year, drawing on top minds in pharma, government, and academia to do it. And now it has an experienced Big Pharma executive leading the charge.
The Trump administration has tapped former GlaxoSmithKline vaccine head Moncef Slaoui to lead the project, which incorporates the Department of Health and Human Services, the Department of Defense, and other agencies to advance promising vaccines against COVID-19, according to reports. Already in the race to create a COVID-19 vaccine, programs from Pfizer, Johnson & Johnson, Sanofi, AstraZeneca, and Moderna, where Slaoui now serves as a board member have generated significant interest as they race ahead.
Moncef Slaoui Coronavirus
In March 2020 Morocco World News reported that Moncef denied in a statement to Moroccan French-language newspaper L’Economiste that he was part of a US government task force to find a vaccine for COVID-19.
He said that he was a part of Moderna’s research and development committee. The committee has received support from federal organizations to help fund the development of a COVID-19 vaccine
“Moderna, which has a very advanced technological platform, was able between January 13, date of reception of the DNA sequence of the virus, and March 25, to design the vaccine, and to produce it in such a way that it can be injected in humans. We will be sure of its protective potential in the coming months. By the end of the year, probably, we will know if it works and we will be able to produce it.”
Moncef Slaoui Operation Warp Speed
Operation Warp Speed first made headlines late last month with a report from Bloomberg detailing the effort spanning numerous government agencies and the military. At the time, the group reportedly aimed to deliver 100 million COVID-19 vaccine doses by the end of the year. But the Associated Press now cites a goal of 300 million.
Also at the Senate hearing this week, National Institute of Allergy and Infectious Diseases chief Anthony Fauci, M.D., said he’s “cautiously optimistic” one or more COVID-19 vaccines in development could work. Asked whether drugs or vaccines will be available in time for students to return to schools this fall, he said that’s a “bridge too far.”
Even as Fauci and others express optimism on the R&D front, some experts believe current vaccine development timelines are unrealistic. SVB Leerink analyst Geoffrey Porges has said creating a vaccine within 12 to 18 months would be as tough as hitting a bull’s-eye with darts from 24 feet on the first try.
Moncef Slaoui Medicine Career
Prior to Medicxi, Moncef was GlaxoSmithKline’s Head of Pharmaceutical R&D and Chairman of its Vaccines division. From this leadership role, Moncef spearheaded a profound overhaul of GSK’s pharmaceutical R&D, resulting in a substantial improvement in productivity, a late-stage pipeline comprising more than 30 phases 3 programs, and a totally redesigned discovery organization comprising 38 highly focused and accountable Discovery Performance Units.
During his career at GSK, he also headed the development of a robust vaccine pipeline, including Rotarix to prevent infantile gastroenteritis, Synflorix to prevent pneumococcal disease, and Cervarix to prevent cervical cancer.
Outside of his role at Medicxi, Moncef is chairman of the board at Galvani Bioelectronics, chairman of the board at SutroVax, and sits on the boards of Artisan Biosciences, Human Vaccines Project, and Moderna Therapeutics.
Moncef received a Ph.D. in Molecular Biology and Immunology from the Université Libre de Bruxelles, Belgium, and completed postdoctoral studies at Harvard Medical School and Tufts University School of Medicine, Boston. He was a professor of Immunology at the University of Mons, Belgium, and has authored more than 100 scientific papers and presentations. A citizen of Morocco, Belgium, and the USA, he is fluent in English, French, and Arabic.
At GSK, Dr. Slaoui has been responsible for the franchise commercial organization, focused on new product launches and lifecycle management. He oversees GSK’s venture capital arm, SR One, and other venture capital partnerships, as well as its groundbreaking Bioelectronics R&D strategy. He is also a member of the Corporate Executive Team and Board of Directors.
Moncef Slaoui Vaccines
Moncef has spent his career attacking the under-researched diseases that plague the developing world. He already has cervical- cancer and a pneumococcal immunization to his credit, and in 2015 he won European approval for the world’s first malaria vaccine, which could limit the spread of disease that kills more than half a million people a year.
Vaccine development is a passion that’s deeply personal for Slaoui: His sister died from whooping cough, an immunizable disease, while they were growing up in Morocco. On his horizon at GlaxoSmithKline: an Ebola Vaccine
He has also published more than 100 scientific papers and is a member of the International AIDS Vaccine Initiative Board of Directors. Moncef was at the helm of GSK’s global vaccine business from 2015 to 2017.
Moncef Slaoui GSK
Moncef has been in GSK for 27years, recently he has been the Global Head for R&D over the past eight and a half years. The GSK post-transaction is clearly in the lead with a 27% market share. GSK Vaccines were founded in 1947; it was a biotech company and it was acquired in 1968 by Smith, Kline & French. Moncef joined the company as a bench scientist in 1988. He was employee number 602 globally. As of today, there are 16000 inclusive of the Novartis transaction.
After leaving GSK, Slaoui became a biopharma venture capitalist and joined the board of Moderna and other companies. He also joined the life sciences investment firm Medicxi as a partner. With the Warp Speed appointment, he’s set to leave the Moderna and other boards, a source told Bloomberg. Shortly after the news broke, patient advocates such as the organization’s Public Citizen raised concerns about potential conflicts of interest.
Slaoui joined the board of the buzzy biotech and other life sciences companies after leaving GSK. Moderna’s shot is now among the leading candidates. Slaoui will now leave the board, however, as he takes on the broader vaccine-leadership role, Moderna said Friday.
Frequently Asked Questions About Moncef Slaoui
Who is Moncef Slaoui?
Moncef Slaoui is the Chairman of Vaccines at GlaxoSmithKline PLC (GSK) and has been responsible for the global vaccines business at GSK through its integration of the Novartis vaccine acquisition in 2015. He is also a Partner at Medicxi and has been with the firm since September 2017. He currently serves on the board of Divide & Conquer, Monopteros, and has an active role in several other Medicxi portfolio companies to support their development.
How old is Moncef Slaoui?
Moncef is 60 years as of 2019, he was born on 27 July 1959 in Agadir, Morocco. Moncef celebrates his birthday on 27th July every year. He will be turning 61 years old on 27 July 2020.
How tall is Moncef Slaoui?
Moncef has not shared his height with the public. His height will be listed once we have it from a credible source.
Is Moncef Slaoui married?
Kristen is married to Moncef, with whom they are blessed with two children.
How much is Moncef Slaoui worth?
Moncef has not yet revealed his net worth. We will update this section when we get and verify information about the wealth and properties under his name.
Where does Moncef Slaoui live?
He is a resident of Philadelphia, Miami, we shall upload pictures of his house as soon as we have them.
Is Moncef Slaoui dead or alive?
Moncef is alive and in good health. There have been no reports of him being sick or having any health-related issues.
Moncef Slaoui Social Media Contacts
Related Biographies.
You may also like to read the Bio, Career, Family, Relationship, Body measurements, Net worth, Achievements, and more about:
- Kristen Belmonte Slaoui
- Dwayne “The Rock” Johnson’s Daughter: Jasmine Johnson
- Brittany Bowe
- Noubar Afeyan
- Dr Thomas Cowan
- Kristen Belmonte Slaoui
- Dr. Tal Zaks
- Kathrin Jansen Pfizer
About InformationCradle Editorial Staff
This Article is produced by InformationCradle Editorial Staff which is a team of expert writers and editors led by Josphat Gachie and trusted by millions of readers worldwide.
We endeavor to keep our content True, Accurate, Correct, Original and Up to Date. For complain, correction or an update, please send us an email to informationcradle@gmail.com. We promise to take corrective measures to the best of our abilities.